IEC 62722:2026 Released for Herbal Extracts

The International Electrotechnical Commission (IEC) officially published IEC 62722:2026, General Technical Specification for Quality Control and Labelling of Herbal Extracts, on 17 May 2026. This update introduces three new mandatory requirements — AI-accelerated microbial limit screening, polyphenol-based active substance fingerprint profiling, and heavy metal migration simulation testing. Exporters and laboratories in China — particularly those accredited by the China National Accreditation Service for Conformity Assessment (CNAS) — have adopted the revised testing protocols, reducing average export certification lead time from 28 to 17 days. The change is especially relevant for enterprises engaged in herbal extract trade with the United States, Japan, and Southeast Asian markets.

Event Overview

On 17 May 2026, the IEC released IEC 62722:2026, specifying updated technical requirements for quality control and labelling of herbal extracts. The standard mandates AI-based rapid microbial screening, multi-polyphenol fingerprint comparison, and simulated heavy metal migration testing. CNAS-accredited laboratories in China have implemented the new testing workflow, resulting in a documented reduction of average export certification duration from 28 days to 17 days.

Industries Affected

Direct Export Trading Firms: These firms face tighter pre-shipment compliance windows due to the new mandatory tests. Delays may arise if documentation or sample preparation does not align with the updated test parameters — particularly for shipments destined for regulated markets such as the U.S. and Japan, where conformity with IEC 62722:2026 may soon be referenced in customs or market surveillance procedures.

Raw Material Sourcing Companies: Suppliers must now ensure upstream botanical materials meet stricter baseline specifications — especially regarding microbiological load and heavy metal content — to avoid retesting or rejection at the extraction or formulation stage. Traceability documentation supporting origin and cultivation practices becomes more critical under the new fingerprint profiling requirement.

Extraction & Formulation Manufacturers: Production workflows may require adjustments to accommodate the new testing schedule and sampling protocols. For example, AI microbial screening demands standardized sample homogenization and digital data submission formats; fingerprint profiling requires consistent solvent systems and HPLC-UV/DAD method validation across batches.

Distribution & Regulatory Support Providers: Third-party compliance consultants and logistics partners handling documentation must update their checklists and training modules to reflect the three new mandatory tests. Certificate of Analysis (CoA) templates now need dedicated fields for AI screening reports, fingerprint match scores, and migration test outcomes.

Key Considerations and Practical Responses

Monitor official implementation timelines in target markets

While IEC 62722:2026 is an international standard, its adoption into national regulatory frameworks (e.g., as a reference in FDA guidance or Japan’s PMDA notifications) remains pending. Enterprises should track updates from national standards bodies and trade agencies — especially in jurisdictions where IEC standards are routinely cited in import clearance procedures.

Validate testing readiness for priority export categories

Not all herbal extract categories carry equal risk under the new requirements. High-polyphenol products (e.g., green tea, grape seed, rosemary extracts) and those prone to heavy metal accumulation (e.g., root-based or soil-grown species) warrant early internal verification. Firms should confirm whether their current CNAS-accredited lab offers full IEC 62722:2026-compliant reporting — including AI screening output format and fingerprint similarity thresholds.

Distinguish between standard publication and enforceable requirement

IEC 62722:2026 is a consensus-based technical specification, not a legally binding regulation. Its immediate impact stems from buyer contractual terms and laboratory accreditation scope — not statutory mandate. Enterprises should review purchase agreements and tender documents to determine whether compliance is contractually required, rather than assuming automatic enforcement.

Align internal sampling, documentation, and batch release protocols

Pre-certification sampling must now support three distinct analytical workflows. Labs require representative sub-samples for microbial screening (aerobic plate count, yeast/mould), fingerprinting (standardized extraction, chromatographic conditions), and migration testing (food-contact simulant selection per intended use). Internal SOPs should explicitly define retention periods, chain-of-custody logging, and metadata tagging for each test stream.

Editorial Perspective / Industry Observation

Observably, IEC 62722:2026 signals a shift toward harmonized, science-driven quality benchmarks for herbal extracts — moving beyond basic identity and assay toward functional consistency and safety predictability. Analysis shows this is less an immediate regulatory trigger and more a forward-looking alignment tool: it reflects growing buyer expectations in mature markets, particularly where botanical ingredients serve functional food, dietary supplement, or cosmetic applications. From an industry perspective, the accelerated certification timeline observed in China suggests that infrastructure adaptation can precede formal regulatory uptake — meaning supply chain actors may experience operational impacts before legal deadlines emerge. Continued monitoring is warranted, as regional authorities may begin referencing the standard in guidance documents within 12–18 months.

Conclusion

IEC 62722:2026 represents a procedural upgrade in quality assurance for herbal extract exports — not a sudden regulatory overhaul. Its primary near-term effect is operational: compressing certification cycles where labs and exporters proactively adopt the framework. For stakeholders, the standard is best understood as an emerging benchmark for market access readiness, rather than an enforceable compliance threshold. Current preparedness hinges less on waiting for government mandates and more on verifying laboratory capability, updating internal quality records, and calibrating supplier expectations against the three new technical requirements.

Information Sources

Main source: Official IEC publication notice for IEC 62722:2026 (released 17 May 2026); public statements from CNAS-accredited laboratories confirming implementation of revised herbal extract testing workflows. Pending observation: Formal referencing of IEC 62722:2026 in national regulatory frameworks or trade agreements remains unconfirmed and requires ongoing tracking.